These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
46-4464131
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
Title of each class
|
|
Name of each exchange on which registered
|
|
Common Stock, $0.01 par value
|
|
New York Stock Exchange
|
|
Large accelerated filer
|
¨
|
|
Accelerated filer
|
x
|
|
Non-accelerated filer
|
¨
|
|
Small reporting company
|
¨
|
|
|
|
|
Emerging growth company
|
x
|
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
•
|
e-commerce
. Our e-commerce business serves as a strong source of sales and an important component of our engagement and innovation model. We have nurtured a loyal, highly active online community for over a decade. Our foundation as an e-commerce company and our digital engagement model drive conversion on elfcosmetics.com, where we sell our full product offering.
|
|
•
|
National retailers
. We currently sell our products in the United States in the mass, drug store, food, and specialty retail channels.
|
|
•
|
International
. e.l.f. products are sold in a number of international markets, including the United Kingdom, Canada, Mexico and Germany.
|
|
•
|
First-to-mass
.
“First-to-mass” products are inspired by trends in prestige beauty that we bring to the mass market. As consumers are increasingly savvy and knowledgeable about trends in the prestige market, they look for how they can achieve on-trend looks, but at an accessible price. Examples include the e.l.f. Mineral Infused Face Primer at $6 versus a prestige primer at $36, e.l.f. Poreless Putty Primer at $8 versus a prestige primer at $52, the e.l.f. Beauty Shield Magnetic Mask at $24 versus a similar type of mask at $75, and the e.l.f. 16HR Camo Concealer at $5 versus a similar type of concealer at $27.
|
|
•
|
Core expansion
.
Core expansion products are those trend-inspired products across eyes, lips, face and tools that augment our assortment and deliver extraordinary value across price points. We consistently evaluate our core offerings and develop new products based on category trends, consumer feedback, and other market intelligence.
|
|
•
|
Adjacencies
.
We believe that we can reapply our model to launch products into adjacent categories. For example, we entered the skin care category in 2015 with a high-quality skin care product assortment.
|
|
•
|
any reduction in consumer traffic and demand at our retail customers as a result of economic downturns, changes in consumer preferences or reputational damage as a result of, among other developments, data privacy breaches, regulatory investigations or employee misconduct;
|
|
•
|
any credit risks associated with the financial condition of our retail customers;
|
|
•
|
the effect of consolidation or weakness in the retail industry or at certain retail customers, including store closures and the resulting uncertainty; and
|
|
•
|
inventory reduction initiatives and other factors affecting retail customer buying patterns, including any reduction in retail space committed to beauty products and retailer practices used to control inventory shrinkage.
|
|
•
|
build a great brand by attracting new consumers and encouraging our current consumers to use more e.l.f. products;
|
|
•
|
continue to use innovation to drive sales and margin and expand into relevant adjacencies;
|
|
•
|
expand brand penetration by growing our space allocations with our existing retail customers, increasing the number of our retail customers, growing our direct-to-consumer business and expanding internationally;
|
|
•
|
leverage our high-performance team culture and executional capability to drive operating margins and efficiencies; and
|
|
•
|
pursue strategic extensions, including by leveraging our capabilities in both the team and infrastructure to extend our platform into other growth areas.
|
|
•
|
we may lose one or more significant retail customers, or sales of our products through these retail customers may decrease;
|
|
•
|
the ability of our third-party suppliers and manufacturers to produce our products and of our distributors to distribute our products could be disrupted;
|
|
•
|
because substantially all of our products are sourced and manufactured in China, our operations are susceptible to risks inherent in doing business there;
|
|
•
|
our products may be the subject of regulatory actions, including but not limited to actions by the FDA, the FTC and the CPSC in the United States;
|
|
•
|
we may be unable to introduce new products that appeal to consumers or otherwise successfully compete with our competitors in the beauty industry;
|
|
•
|
we may be unsuccessful in enhancing the recognition and reputation of our brand, and our brand may be damaged as a result of, among other reasons, our failure, or alleged failure, to comply with applicable ethical, social, product, labor or environmental standards;
|
|
•
|
we may experience service interruptions, data corruption, cyber-based attacks or network security breaches which result in the disruption of our operating systems or the loss of confidential information of our consumers;
|
|
•
|
we may be unable to retain key members of our senior management team or attract and retain other qualified personnel; and
|
|
•
|
we may be affected by any adverse economic conditions in the United States or internationally.
|
|
•
|
have economic or business interests or goals that are inconsistent with ours;
|
|
•
|
take actions contrary to our instructions, requests, policies or objectives;
|
|
•
|
be unable or unwilling to fulfill their obligations under relevant purchase orders, including obligations to meet our production deadlines, quality standards, pricing guidelines and product specifications, or to comply with applicable regulations, including those regarding the safety and quality of products and ingredients and good manufacturing practices;
|
|
•
|
have financial difficulties;
|
|
•
|
encounter raw material or labor shortages;
|
|
•
|
encounter increases in raw material or labor costs which may affect our procurement costs;
|
|
•
|
disclose our confidential information or intellectual property to competitors or third parties;
|
|
•
|
engage in activities or employ practices that may harm our reputation; and
|
|
•
|
work with, be acquired by, or come under control of, our competitors.
|
|
•
|
requiring a substantial portion of our cash flows to be dedicated to debt service payments instead of funding growth, working capital, capital expenditures, investments or other cash requirements;
|
|
•
|
reducing our flexibility to adjust to changing business conditions or obtain additional financing;
|
|
•
|
exposing us to the risk of increased interest rates as our borrowings are at variable rates;
|
|
•
|
making it more difficult for us to make payments on our indebtedness;
|
|
•
|
subjecting us to restrictive covenants that may limit our flexibility in operating our business, including our ability to take certain actions with respect to indebtedness, liens, sales of assets, consolidations and mergers, affiliate transactions, dividends and other distributions and changes of control;
|
|
•
|
subjecting us to maintenance covenants which require us to maintain specific financial ratios; and
|
|
•
|
limiting our ability to obtain additional financing for working capital, capital expenditures, debt service requirements and general corporate or other purposes.
|
|
•
|
difficulties in staffing and managing foreign operations;
|
|
•
|
burdens of complying with a wide variety of laws and regulations, including more stringent regulations relating to data privacy and security, particularly in the European Union;
|
|
•
|
adverse tax effects and foreign exchange controls making it difficult to repatriate earnings and cash;
|
|
•
|
political and economic instability;
|
|
•
|
terrorist activities and natural disasters;
|
|
•
|
trade restrictions;
|
|
•
|
differing employment practices and laws and labor disruptions;
|
|
•
|
the imposition of government controls;
|
|
•
|
an inability to use or to obtain adequate intellectual property protection for our key brands and products;
|
|
•
|
tariffs and customs duties and the classifications of our goods by applicable governmental bodies;
|
|
•
|
a legal system subject to undue influence or corruption;
|
|
•
|
a business culture in which illegal sales practices may be prevalent;
|
|
•
|
logistics and sourcing;
|
|
•
|
military conflicts; and
|
|
•
|
acts of terrorism.
|
|
•
|
potentially increased regulatory and compliance requirements;
|
|
•
|
implementation or remediation of controls, procedures and policies at the acquired company;
|
|
•
|
diversion of management time and focus from operation of our then-existing business to acquisition integration challenges;
|
|
•
|
coordination of product, sales, marketing and program and systems management functions;
|
|
•
|
transition of the acquired company’s users and customers onto our systems;
|
|
•
|
retention of employees from the acquired company;
|
|
•
|
integration of employees from the acquired company into our organization;
|
|
•
|
integration of the acquired company’s accounting, information management, human resources and other administrative systems and operations into our systems and operations;
|
|
•
|
liability for activities of the acquired company prior to the acquisition, including violations of law, commercial disputes and tax and other known and unknown liabilities; and
|
|
•
|
litigation or other claims in connection with the acquired company, including claims brought by terminated employees, customers, former stockholders or other third parties.
|
|
•
|
authorize, issue or enter into any agreement providing for the issuance (contingent or otherwise) of (x) any notes or debt securities with options, warrants or other rights to acquire equity securities or otherwise containing profit participation features or (y) any equity securities other than equity securities issued to employees, directors, consultants or advisors pursuant to a plan, agreement or arrangement approved by our board of directors;
|
|
•
|
liquidate, dissolve or effect a recapitalization or reorganization in any form of transaction or series of transactions;
|
|
•
|
incur any indebtedness in an aggregate amount in excess of $50.0 million (other than indebtedness under the terms and provisions of the Credit Agreement); and
|
|
•
|
increase or decrease the size of our board of directors.
|
|
•
|
although we do not have a stockholder rights plan, these provisions allow us to authorize the issuance of undesignated preferred stock in connection with a stockholder rights plan or otherwise, the terms of which may be established and the shares of which may be issued without stockholder approval, and which may include super voting, special approval, dividend or other rights or preferences superior to the rights of the holders of common stock;
|
|
•
|
these provisions provide for a classified board of directors with staggered three-year terms;
|
|
•
|
these provisions require advance notice for nominations of directors by stockholders, subject to the Stockholders Agreement, and for stockholders to include matters to be considered at our annual meetings;
|
|
•
|
these provisions prohibit stockholder action by written consent;
|
|
•
|
these provisions provide for the removal of directors only for cause and only upon affirmative vote of holders of at least 75% of the shares of common stock entitled to vote generally in the election of directors; and
|
|
•
|
these provisions require the amendment of certain provisions only by the affirmative vote of at least 75% of the shares of common stock entitled to vote generally in the election of directors.
|
|
•
|
engage an independent registered public accounting firm to report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”);
|
|
•
|
comply with any requirement that may be adopted by the PCAOB, regarding mandatory audit firm rotation or a supplement to the independent registered public accounting firm’s report providing additional information about the audit and the financial statements (i.e., an auditor discussion and analysis);
|
|
•
|
submit certain executive compensation matters to stockholder advisory votes, such as “say-on-pay,” “say-on-frequency” and “say-on-golden parachutes;” or
|
|
•
|
disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the chief executive officer’s compensation to median employee compensation.
|
|
$100 investment in stock or index
|
|
9/22/2016
|
|
9/30/2016
|
|
12/31/2016
|
|
3/31/2017
|
|
6/30/2017
|
|
9/30/2017
|
|
12/31/2017
|
|
3/31/2018
|
|
6/30/2018
|
|
9/30/2018
|
|
12/31/2018
|
||||||||||||||||||||||
|
e.l.f. Beauty, Inc. (ELF)
|
|
$
|
100.00
|
|
|
$
|
106.11
|
|
|
$
|
109.21
|
|
|
$
|
108.68
|
|
|
$
|
102.68
|
|
|
$
|
85.09
|
|
|
$
|
84.19
|
|
|
$
|
73.09
|
|
|
$
|
57.51
|
|
|
$
|
48.04
|
|
|
$
|
32.68
|
|
|
S&P 500 Index (GSPC)
|
|
$
|
100.00
|
|
|
$
|
99.59
|
|
|
$
|
102.83
|
|
|
$
|
108.52
|
|
|
$
|
111.31
|
|
|
$
|
115.72
|
|
|
$
|
122.80
|
|
|
$
|
121.30
|
|
|
$
|
124.86
|
|
|
$
|
133.84
|
|
|
$
|
115.14
|
|
|
S&P 500 Consumer Discretionary Index (S5COND)
|
|
$
|
100.00
|
|
|
$
|
100.23
|
|
|
$
|
102.54
|
|
|
$
|
111.21
|
|
|
$
|
113.82
|
|
|
$
|
114.78
|
|
|
$
|
126.10
|
|
|
$
|
130.01
|
|
|
$
|
140.63
|
|
|
$
|
152.13
|
|
|
$
|
127.15
|
|
|
|
Successor
|
|
Unaudited
pro forma
combined
(1)
|
|
Successor
(2)
|
|
|
Predecessor
|
||||||||||||||||||||
|
(dollars in thousands, except share
and per share amounts)
|
Year ended December 31, 2018
|
|
Year ended
December 31, 2017
|
|
Year ended
December 31, 2016
|
|
Year ended
December 31, 2015
|
|
Year ended
December 31, 2014
|
|
Period from
February 1, 2014
through
December 31, 2014
|
|
|
Period from
January 1, 2014
through
January 31, 2014
|
||||||||||||||
|
Statement of operations data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Net sales
|
$
|
267,435
|
|
|
$
|
269,888
|
|
|
$
|
229,567
|
|
|
$
|
191,413
|
|
|
$
|
144,944
|
|
|
$
|
135,134
|
|
|
|
$
|
9,810
|
|
|
Gross profit
|
162,741
|
|
|
164,725
|
|
|
132,235
|
|
|
100,329
|
|
|
67,496
|
|
|
61,450
|
|
|
|
4,772
|
|
|||||||
|
Operating income
|
26,162
|
|
|
33,279
|
|
|
23,079
|
|
|
25,571
|
|
|
16,119
|
|
|
5,347
|
|
|
|
1,727
|
|
|||||||
|
Other income (expense), net
|
(390
|
)
|
|
(2,035
|
)
|
|
3,016
|
|
|
(4,172
|
)
|
|
(6,597
|
)
|
|
(6,633
|
)
|
|
|
36
|
|
|||||||
|
Interest expense, net
|
(7,816
|
)
|
|
(8,775
|
)
|
|
(16,283
|
)
|
|
(12,721
|
)
|
|
(12,546
|
)
|
|
(11,545
|
)
|
|
|
(128
|
)
|
|||||||
|
Income (loss) before provision for income taxes
|
17,956
|
|
|
22,469
|
|
|
9,812
|
|
|
8,678
|
|
|
(3,024
|
)
|
|
(12,831
|
)
|
|
|
1,635
|
|
|||||||
|
Income tax benefit (provision)
|
(2,431
|
)
|
|
11,006
|
|
|
(4,499
|
)
|
|
(4,321
|
)
|
|
143
|
|
|
3,545
|
|
|
|
(542
|
)
|
|||||||
|
Net income (loss)
|
$
|
15,525
|
|
|
$
|
33,475
|
|
|
$
|
5,313
|
|
|
$
|
4,357
|
|
|
$
|
(2,881
|
)
|
|
$
|
(9,286
|
)
|
|
|
$
|
1,093
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net income (loss) per share - basic
|
$
|
0.33
|
|
|
$
|
0.74
|
|
|
$
|
(39.47
|
)
|
|
$
|
(1,559.81
|
)
|
|
$
|
(512.00
|
)
|
|
$
|
(709.35
|
)
|
|
|
$
|
1,093.00
|
|
|
Net income (loss) per share - diluted
|
$
|
0.32
|
|
|
$
|
0.68
|
|
|
$
|
(39.47
|
)
|
|
$
|
(1,559.81
|
)
|
|
$
|
(512.00
|
)
|
|
$
|
(709.35
|
)
|
|
|
$
|
1,087.56
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Other data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Depreciation and amortization
|
$
|
17,861
|
|
|
$
|
14,521
|
|
|
$
|
13,152
|
|
|
$
|
10,289
|
|
|
$
|
8,668
|
|
|
$
|
7,944
|
|
|
|
$
|
41
|
|
|
Capital expenditures
|
8,872
|
|
|
7,544
|
|
|
9,223
|
|
|
10,242
|
|
|
1,616
|
|
|
1,597
|
|
|
|
19
|
|
|||||||
|
(1)
|
For the purpose of performing a comparison to the year ended December 31, 2015, we prepared unaudited pro forma combined supplemental financial information for the year ended December 31, 2014, which gives effect to the acquisition of 100% of the outstanding shares of capital stock of e.l.f. Cosmetics, Inc. (formerly known as J.A. Cosmetics US, Inc.), as if it had occurred on January 1, 2014 (the “Unaudited Pro Forma Combined 2014 Period”). The Unaudited Pro Forma Combined 2014 Period is included in the table above being discussed herein for informational purposes only and does not reflect any operating efficiencies or potential cost savings that may result from the consolidation of operations.
|
|
(2)
|
For purposes of the table above, “Successor” refers to e.l.f. Beauty, Inc. (and its subsidiaries) after the acquisition by e.l.f. Beauty, Inc. of 100% of the outstanding shares of capital stock of e.l.f. Cosmetics, Inc. and “Predecessor” refers to e.l.f. Cosmetics, Inc. (and its subsidiaries) prior to the acquisition by e.l.f. Beauty, Inc. of 100% of the outstanding shares of capital stock of e.l.f. Cosmetics, Inc.
|
|
(dollars in thousands)
|
December 31, 2018
|
|
December 31, 2017
|
|
December 31, 2016
|
|
December 31, 2015
|
|
December 31, 2014
|
||||||||||
|
Balance sheet data:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cash and cash equivalents
|
$
|
51,205
|
|
|
$
|
10,059
|
|
|
$
|
15,295
|
|
|
$
|
14,004
|
|
|
$
|
4,668
|
|
|
Net working capital
(3)
|
47,523
|
|
|
62,224
|
|
|
29,339
|
|
|
10,860
|
|
|
23,218
|
|
|||||
|
Property and equipment, net
|
21,804
|
|
|
18,037
|
|
|
17,151
|
|
|
9,854
|
|
|
2,125
|
|
|||||
|
Total assets
|
435,856
|
|
|
417,244
|
|
|
414,729
|
|
|
361,072
|
|
|
354,178
|
|
|||||
|
Capital leases
|
3,982
|
|
|
2,374
|
|
|
2,766
|
|
|
—
|
|
|
—
|
|
|||||
|
Debt, including current maturities
(4)
|
146,402
|
|
|
153,974
|
|
|
162,061
|
|
|
144,919
|
|
|
148,424
|
|
|||||
|
Total liabilities
|
206,525
|
|
|
223,381
|
|
|
273,867
|
|
|
224,175
|
|
|
222,656
|
|
|||||
|
Convertible preferred stock
|
—
|
|
|
—
|
|
|
—
|
|
|
197,295
|
|
|
145,328
|
|
|||||
|
Total stockholders' equity (deficit)
|
229,331
|
|
|
193,863
|
|
|
140,862
|
|
|
(60,398
|
)
|
|
(13,806
|
)
|
|||||
|
(3)
|
Net working capital is defined as current assets, excluding cash and cash equivalents, minus current liabilities.
|
|
(4)
|
Total bank debt, including current maturities, is net of
$0.3 million
, $0.4 million, $0.6 million, $3.2 million and $4.3 million of debt issuance costs as of
December 31, 2018
,
2017
,
2016
,
2015
and 2014, respectively.
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Net sales
|
$
|
267,435
|
|
|
$
|
269,888
|
|
|
$
|
229,567
|
|
|
Cost of sales
|
104,694
|
|
|
105,163
|
|
|
97,332
|
|
|||
|
Gross profit
|
162,741
|
|
|
164,725
|
|
|
132,235
|
|
|||
|
Selling, general, and administrative expenses
|
136,579
|
|
|
131,446
|
|
|
109,156
|
|
|||
|
Operating income
|
26,162
|
|
|
33,279
|
|
|
23,079
|
|
|||
|
Other income (expense), net
|
(390
|
)
|
|
(2,035
|
)
|
|
3,016
|
|
|||
|
Interest expense, net
|
(7,816
|
)
|
|
(8,775
|
)
|
|
(16,283
|
)
|
|||
|
Income before provision for income taxes
|
17,956
|
|
|
22,469
|
|
|
9,812
|
|
|||
|
Income tax benefit (provision)
|
(2,431
|
)
|
|
11,006
|
|
|
(4,499
|
)
|
|||
|
Net income
|
$
|
15,525
|
|
|
$
|
33,475
|
|
|
$
|
5,313
|
|
|
Comprehensive income
|
$
|
15,525
|
|
|
$
|
33,475
|
|
|
$
|
5,313
|
|
|
|
Year ended December 31,
|
|||||||
|
(percentage of net sales)
|
2018
|
|
2017
|
|
2016
|
|||
|
Net sales
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
Cost of sales
|
39
|
%
|
|
39
|
%
|
|
42
|
%
|
|
Gross margin
|
61
|
%
|
|
61
|
%
|
|
58
|
%
|
|
Selling, general, and administrative expenses
|
51
|
%
|
|
49
|
%
|
|
48
|
%
|
|
Operating income
|
10
|
%
|
|
12
|
%
|
|
10
|
%
|
|
Other income (expense), net
|
—
|
%
|
|
(1
|
)%
|
|
1
|
%
|
|
Interest expense, net
|
(3
|
)%
|
|
(3
|
)%
|
|
(7
|
)%
|
|
Income before provision for income taxes
|
7
|
%
|
|
8
|
%
|
|
4
|
%
|
|
Income tax benefit (provision)
|
(1
|
)%
|
|
4
|
%
|
|
(2
|
)%
|
|
Net income
|
6
|
%
|
|
12
|
%
|
|
2
|
%
|
|
Comprehensive income
|
6
|
%
|
|
12
|
%
|
|
2
|
%
|
|
|
Year ended December 31,
|
||||||||||
|
(in thousands)
|
2018
|
|
2017
|
|
2016
|
||||||
|
Net cash provided by (used in):
|
|
|
|
|
|
||||||
|
Operating activities
|
$
|
55,582
|
|
|
$
|
12,378
|
|
|
$
|
2,120
|
|
|
Investing activities
|
(8,872
|
)
|
|
(10,419
|
)
|
|
(9,139
|
)
|
|||
|
Financing activities
|
(5,564
|
)
|
|
(7,195
|
)
|
|
8,310
|
|
|||
|
Net increase (decrease) in cash:
|
$
|
41,146
|
|
|
$
|
(5,236
|
)
|
|
$
|
1,291
|
|
|
|
Payments Due by Period
|
||||||||||||||||||
|
|
Total
|
|
Less than 1 Year
|
|
1-3 Years
|
|
3-5 Years
|
|
More than 5 Years
|
||||||||||
|
Bank debt
(1)
|
$
|
148,500
|
|
|
$
|
9,075
|
|
|
$
|
25,575
|
|
|
$
|
113,850
|
|
|
$
|
—
|
|
|
Interest on bank debt
(2)
|
19,650
|
|
|
5,995
|
|
|
10,699
|
|
|
2,956
|
|
|
—
|
|
|||||
|
Operating lease obligations
|
27,318
|
|
|
5,375
|
|
|
9,086
|
|
|
5,690
|
|
|
7,167
|
|
|||||
|
Capital lease obligations
(3)
|
4,499
|
|
|
976
|
|
|
1,885
|
|
|
1,638
|
|
|
—
|
|
|||||
|
Total contractual obligations
(4)
|
$
|
199,967
|
|
|
$
|
21,421
|
|
|
$
|
47,245
|
|
|
$
|
124,134
|
|
|
$
|
7,167
|
|
|
(1)
|
Long-term debt payments include scheduled principal payments only.
|
|
(2)
|
Assumes an annual interest rate of
4.8%
on the Credit Agreement over the term of the loan.
|
|
(3)
|
Includes a $0.3 million residual value guarantee.
|
|
(4)
|
We have excluded our liability for uncertain tax positions from the table above because we are unable to make a reasonably reliable estimate of the timing of payments.
|
|
e.l.f. Beauty, Inc. and subsidiaries
|
|
|
Index to consolidated financial statements
|
|
|
|
Page
|
|
|
|
|
Incorporated by Reference
|
|||
|
Exhibit Number
|
Exhibit Description
|
Provided
Herewith
|
Form
|
Exhibit
Number
|
File Number
|
Filing Date
|
|
|
|
|
|
|
|
|
|
3.1
|
|
8-K
|
3.1
|
001-37873
|
9/27/2016
|
|
|
|
|
|
|
|
|
|
|
3.2
|
|
8-K
|
3.2
|
001-37873
|
9/27/2016
|
|
|
|
|
|
|
|
|
|
|
4.1
|
Reference is made to exhibits 3.1 and 3.2.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.2
|
|
S-1
|
4.2
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
4.3
|
|
8-K
|
10.1
|
001-37873
|
3/3/2017
|
|
|
|
|
|
|
|
|
|
|
4.4
|
|
S-1/A
|
4.4
|
333-213333
|
9/12/2016
|
|
|
|
|
|
|
|
|
|
|
10.1
|
|
S-1
|
10.1
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
10.2
|
|
S-1
|
10.2
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
10.3
|
|
S-1
|
10.3
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
10.4
|
|
S-1
|
10.4
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
10.5
|
|
S-1
|
10.5
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
10.6
|
|
8-K
|
10.1
|
001-37873
|
12/28/2016
|
|
|
|
|
|
|
|
|
|
|
10.7
|
|
8-K
|
10.1
|
001-37873
|
8/28/2017
|
|
|
|
|
|
|
|
|
|
|
10.8(a)#
|
|
S-1
|
10.12
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
10.8(b)#
|
|
10-K
|
10.7(b)
|
001-3783
|
3/15/2017
|
|
|
|
|
|
Incorporated by Reference
|
|||
|
Exhibit Number
|
Exhibit Description
|
Provided
Herewith
|
Form
|
Exhibit
Number
|
File Number
|
Filing Date
|
|
10.8(c)#
|
|
S-1
|
10.13
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
10.9(a)#
|
|
S-1/A
|
10.16
|
333-213333
|
9/12/2016
|
|
|
|
|
|
|
|
|
|
|
10.9(b)#
|
|
S-1/A
|
10.17
|
333-213333
|
9/12/2016
|
|
|
|
|
|
|
|
|
|
|
10.9(c)#
|
|
S-1/A
|
10.27
|
333-213333
|
9/12/2016
|
|
|
|
|
|
|
|
|
|
|
10.9(d)#
|
|
10-K
|
10.12(d)
|
001-3783
|
3/15/2017
|
|
|
|
|
|
|
|
|
|
|
10.9(e)#
|
|
10-K
|
10.12(e)
|
001-3783
|
3/15/2017
|
|
|
|
|
|
|
|
|
|
|
10.10#
|
|
S-1/A
|
10.18
|
333-213333
|
9/12/2016
|
|
|
|
|
|
|
|
|
|
|
10.11#
|
|
S-1
|
10.19
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
10.12#
|
|
S-1
|
10.20
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
10.13#
|
|
S-1
|
10.21
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
10.14#
|
|
S-1
|
10.22
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incorporated by Reference
|
|||
|
Exhibit Number
|
Exhibit Description
|
Provided
Herewith
|
Form
|
Exhibit
Number
|
File Number
|
Filing Date
|
|
|
|
|
|
|
|
|
|
10.15#
|
|
S-1
|
10.24
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
10.16#
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.17#
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.18#
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.19#
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.20#
|
|
S-1
|
10.25
|
333-213333
|
8/26/2016
|
|
|
|
|
|
|
|
|
|
|
10.21#
|
|
S-1/A
|
10.26
|
333-213333
|
9/12/2016
|
|
|
|
|
|
|
|
|
|
|
21.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.2
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.1*
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS
101.SCH
101.CAL
101.LAB
101.PRE
101.DEF
|
XBRL Instance.
XBRL Taxonomy Extension Schema.
XBRL Taxonomy Extension Calculation Linkbase.
XBRL Taxonomy Extension Label Linkbase.
XBRL Taxonomy Extension Presentation Linkbase.
XBRL Taxonomy Extension Definition Linkbase.
|
X
X
X
X
X
X
|
|
|
|
|
|
#
|
Indicates management contract or compensatory plan
|
|
*
|
This certification is deemed furnished, and not filed, with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of e.l.f. Beauty, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any general incorporation language contained in such filing.
|
|
|
|
e.l.f. Beauty, Inc.
|
|
|
|
|
|
|
|
February 28, 2019
|
|
By:
|
/s/ Tarang P. Amin
|
|
Date
|
|
|
Tarang P. Amin
Chairman and Chief Executive Officer
|
|
|
|
|
|
|
February 28, 2019
|
|
By:
|
/s/ John P. Bailey
|
|
Date
|
|
|
John P. Bailey
President and Chief Financial Officer
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ Tarang P. Amin
|
|
Chairman, Chief Executive Officer and Director
(Principal Executive Officer)
|
|
February 22, 2019
|
|
Tarang P. Amin
|
|
|
|
|
|
|
|
|
|
|
|
/s/ John P. Bailey
|
|
President and Chief Financial Officer
(Principal Financial and Accounting Officer)
|
|
February 26, 2019
|
|
John P. Bailey
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Lauren Cooks Levitan
|
|
Director
|
|
February 23, 2019
|
|
Lauren Cooks Levitan
|
|
|
|
|
|
|
|
|
|
|
|
/s/ William E. McGlashan, Jr.
|
|
Director
|
|
February 23, 2019
|
|
William E. McGlashan, Jr.
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Richelle P. Parham
|
|
Director
|
|
February 22, 2019
|
|
Richelle P. Parham
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Kirk L. Perry
|
|
Director
|
|
February 24, 2019
|
|
Kirk L. Perry
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Beth M. Pritchard
|
|
Director
|
|
February 23, 2019
|
|
Beth M. Pritchard
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Sabrina L. Simmons
|
|
Director
|
|
February 22, 2019
|
|
Sabrina L. Simmons
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Maureen C. Watson
|
|
Director
|
|
February 27, 2019
|
|
Maureen C. Watson
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Richard G. Wolford
|
|
Director
|
|
February 27, 2019
|
|
Richard G. Wolford
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||
|
Assets
|
|
|
|
|
|
||
|
Current assets:
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
$
|
51,205
|
|
|
$
|
10,059
|
|
|
Accounts receivable, net
|
36,724
|
|
|
44,634
|
|
||
|
Inventory, net
|
46,341
|
|
|
62,679
|
|
||
|
Prepaid expenses and other current assets
|
7,473
|
|
|
6,272
|
|
||
|
Total current assets
|
141,743
|
|
|
123,644
|
|
||
|
Property and equipment, net
|
21,804
|
|
|
18,037
|
|
||
|
Intangible assets, net
|
98,773
|
|
|
105,882
|
|
||
|
Goodwill
|
157,264
|
|
|
157,264
|
|
||
|
Investments
|
2,875
|
|
|
2,875
|
|
||
|
Other assets
|
13,397
|
|
|
9,542
|
|
||
|
Total assets
|
$
|
435,856
|
|
|
$
|
417,244
|
|
|
|
|
|
|
||||
|
Liabilities and stockholders' equity
|
|
|
|
|
|
||
|
Current liabilities:
|
|
|
|
|
|
||
|
Current portion of long-term debt and capital lease obligations
|
$
|
9,861
|
|
|
$
|
8,646
|
|
|
Accounts payable
|
20,483
|
|
|
26,776
|
|
||
|
Accrued expenses and other current liabilities
|
12,671
|
|
|
15,939
|
|
||
|
Total current liabilities
|
43,015
|
|
|
51,361
|
|
||
|
Long-term debt and capital lease obligations
|
140,523
|
|
|
147,702
|
|
||
|
Deferred tax liabilities
|
20,217
|
|
|
21,341
|
|
||
|
Other long-term liabilities
|
2,770
|
|
|
2,977
|
|
||
|
Total liabilities
|
206,525
|
|
|
223,381
|
|
||
|
|
|
|
|
||||
|
Commitments and contingencies (Note 9)
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Stockholders' equity:
|
|
|
|
|
|
||
|
Common stock, par value of $0.01 per share;
250,000,000 shares authorized as of December 31, 2018 and December 31, 2017; 48,715,276
and 46,617,830 shares issued and outstanding as of December 31, 2018 and December 31, 2017, respectively
|
478
|
|
|
463
|
|
||
|
Additional paid-in capital
|
740,354
|
|
|
720,372
|
|
||
|
Accumulated deficit
|
(511,501
|
)
|
|
(526,972
|
)
|
||
|
Total stockholders' equity
|
229,331
|
|
|
193,863
|
|
||
|
Total liabilities and stockholders' equity
|
$
|
435,856
|
|
|
$
|
417,244
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Net sales
|
$
|
267,435
|
|
|
$
|
269,888
|
|
|
$
|
229,567
|
|
|
Cost of sales
|
104,694
|
|
|
105,163
|
|
|
97,332
|
|
|||
|
Gross profit
|
162,741
|
|
|
164,725
|
|
|
132,235
|
|
|||
|
Selling, general, and administrative expenses
|
136,579
|
|
|
131,446
|
|
|
109,156
|
|
|||
|
Operating income
|
26,162
|
|
|
33,279
|
|
|
23,079
|
|
|||
|
Other income (expense), net
|
(390
|
)
|
|
(2,035
|
)
|
|
3,016
|
|
|||
|
Interest expense, net
|
(7,816
|
)
|
|
(8,775
|
)
|
|
(16,283
|
)
|
|||
|
Income before provision for income taxes
|
17,956
|
|
|
22,469
|
|
|
9,812
|
|
|||
|
Income tax benefit (provision)
|
(2,431
|
)
|
|
11,006
|
|
|
(4,499
|
)
|
|||
|
Net income
|
$
|
15,525
|
|
|
$
|
33,475
|
|
|
$
|
5,313
|
|
|
Comprehensive income
|
$
|
15,525
|
|
|
$
|
33,475
|
|
|
$
|
5,313
|
|
|
Net income (loss) per share:
|
|
|
|
|
|
|
|||||
|
Basic
|
$
|
0.33
|
|
|
$
|
0.74
|
|
|
$
|
(39.47
|
)
|
|
Diluted
|
$
|
0.32
|
|
|
$
|
0.68
|
|
|
$
|
(39.47
|
)
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|||||
|
Basic
|
46,828,798
|
|
|
45,358,452
|
|
|
12,606,529
|
|
|||
|
Diluted
|
49,268,616
|
|
|
49,374,758
|
|
|
12,606,529
|
|
|||
|
|
Convertible preferred stock
|
|
|
Common stock
|
|
Employee
note
receivable
|
|
Additional
paid-in
capital
|
|
Accumulated deficit
|
|
Total
stockholders'
equity (deficit)
|
|||||||||||||||||||
|
|
Shares
|
|
Amount
|
|
|
Shares
|
|
Amount
|
|
|
|
|
|||||||||||||||||||
|
Balance as of December 31, 2015
|
135,041
|
|
|
$
|
197,295
|
|
|
|
34,493
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6,785
|
|
|
$
|
(67,183
|
)
|
|
$
|
(60,398
|
)
|
|
|
Net income
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,313
|
|
|
5,313
|
|
|||||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,149
|
|
|
—
|
|
|
7,149
|
|
|||||||
|
Dividend paid
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,801
|
)
|
|
(62,259
|
)
|
|
(72,060
|
)
|
|||||||
|
Issuance of employee note receivable
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
(11,932
|
)
|
|
—
|
|
|
—
|
|
|
(11,932
|
)
|
|||||||
|
Accrued interest on employee note receivable
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
(39
|
)
|
|
39
|
|
|
—
|
|
|
—
|
|
|||||||
|
Repayment of employee note receivable
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
11,971
|
|
|
—
|
|
|
—
|
|
|
11,971
|
|
|||||||
|
Convertible preferred stock accretion
|
—
|
|
|
436,317
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(436,317
|
)
|
|
(436,317
|
)
|
|||||||
|
Conversion of preferred stock
|
(135,041
|
)
|
|
(633,612
|
)
|
|
|
37,271,375
|
|
|
372
|
|
|
—
|
|
|
633,240
|
|
|
—
|
|
|
633,612
|
|
|||||||
|
Issuance of common stock upon initial public offering
|
—
|
|
|
—
|
|
|
|
4,000,000
|
|
|
40
|
|
|
—
|
|
|
63,200
|
|
|
—
|
|
|
63,240
|
|
|||||||
|
Vesting of early exercised stock options
|
—
|
|
|
—
|
|
|
|
2,169,003
|
|
|
22
|
|
|
—
|
|
|
7,837
|
|
|
—
|
|
|
7,859
|
|
|||||||
|
Exercise of stock options, net
|
—
|
|
|
—
|
|
|
|
278,440
|
|
|
3
|
|
|
—
|
|
|
828
|
|
|
—
|
|
|
831
|
|
|||||||
|
Deferred offering costs
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(8,406
|
)
|
|
—
|
|
|
(8,406
|
)
|
|||||||
|
Balance as of December 31, 2016
|
—
|
|
|
—
|
|
|
|
43,753,311
|
|
|
438
|
|
|
—
|
|
|
700,871
|
|
|
(560,447
|
)
|
|
140,862
|
|
|||||||
|
Net income
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
33,475
|
|
|
33,475
|
|
|||||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,474
|
|
|
—
|
|
|
13,474
|
|
|||||||
|
Vesting of early exercised stock options
|
—
|
|
|
—
|
|
|
|
1,522,826
|
|
|
15
|
|
|
—
|
|
|
4,059
|
|
|
—
|
|
|
4,074
|
|
|||||||
|
Exercise of stock options, net
|
—
|
|
|
—
|
|
|
|
1,039,493
|
|
|
10
|
|
|
—
|
|
|
1,968
|
|
|
—
|
|
|
1,978
|
|
|||||||
|
Balance as of December 31, 2017
|
—
|
|
|
—
|
|
|
|
46,315,630
|
|
|
463
|
|
|
—
|
|
|
720,372
|
|
|
(526,972
|
)
|
|
193,863
|
|
|||||||
|
Net income
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,525
|
|
|
15,525
|
|
|||||||
|
Stock-based compensation
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
16,821
|
|
|
—
|
|
|
16,821
|
|
|||||||
|
Exercise of stock options, net
|
—
|
|
|
—
|
|
|
|
1,514,126
|
|
|
15
|
|
|
—
|
|
|
3,161
|
|
|
—
|
|
|
3,176
|
|
|||||||
|
Adoption of new accounting standard
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
(54
|
)
|
|
(54
|
)
|
||||||
|
Balance as of December 31, 2018
|
—
|
|
|
$
|
—
|
|
|
|
47,829,756
|
|
|
$
|
478
|
|
|
$
|
—
|
|
|
$
|
740,354
|
|
|
$
|
(511,501
|
)
|
|
$
|
229,331
|
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|||
|
Net income
|
$
|
15,525
|
|
|
$
|
33,475
|
|
|
$
|
5,313
|
|
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
|
|
|
||||||
|
Depreciation and amortization
|
17,861
|
|
|
14,521
|
|
|
13,152
|
|
|||
|
Stock-based compensation expense
|
16,821
|
|
|
13,474
|
|
|
7,149
|
|
|||
|
Amortization of debt issuance costs and discount on debt
|
792
|
|
|
810
|
|
|
1,281
|
|
|||
|
Deferred income taxes
|
(939
|
)
|
|
(13,434
|
)
|
|
(7,575
|
)
|
|||
|
Debt prepayment penalty
|
—
|
|
|
—
|
|
|
2,736
|
|
|||
|
Loss/(gain) on foreign currency forward contracts
|
—
|
|
|
—
|
|
|
(10,702
|
)
|
|||
|
Other, net
|
476
|
|
|
1,728
|
|
|
247
|
|
|||
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
||||
|
Accounts receivable
|
7,649
|
|
|
(8,001
|
)
|
|
(15,392
|
)
|
|||
|
Inventories
|
16,338
|
|
|
6,718
|
|
|
(37,994
|
)
|
|||
|
Prepaid expenses and other assets
|
(8,484
|
)
|
|
(11,200
|
)
|
|
(635
|
)
|
|||
|
Accounts payable and accrued expenses
|
(10,251
|
)
|
|
(25,483
|
)
|
|
43,144
|
|
|||
|
Other liabilities
|
(206
|
)
|
|
(230
|
)
|
|
1,396
|
|
|||
|
Net cash provided by operating activities
|
55,582
|
|
|
12,378
|
|
|
2,120
|
|
|||
|
|
|
|
|
|
|
||||||
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
||||
|
Purchase of property and equipment
|
(8,872
|
)
|
|
(7,544
|
)
|
|
(9,223
|
)
|
|||
|
Investment in equity securities
|
—
|
|
|
(2,875
|
)
|
|
—
|
|
|||
|
Other, net
|
—
|
|
|
—
|
|
|
84
|
|
|||
|
Net cash used in investing activities
|
(8,872
|
)
|
|
(10,419
|
)
|
|
(9,139
|
)
|
|||
|
|
|
|
|
|
|
||||||
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
||||
|
Proceeds from revolving line of credit
|
2,000
|
|
|
25,900
|
|
|
5,500
|
|
|||
|
Repayment of revolving line of credit
|
(2,000
|
)
|
|
(25,900
|
)
|
|
(13,200
|
)
|
|||
|
Proceeds from long-term debt
|
—
|
|
|
—
|
|
|
172,749
|
|
|||
|
Repayment of long-term debt
|
(8,250
|
)
|
|
(8,250
|
)
|
|
(151,540
|
)
|
|||
|
Debt issuance costs paid
|
—
|
|
|
(519
|
)
|
|
(704
|
)
|
|||
|
Cash received from issuance of common stock
|
3,176
|
|
|
1,978
|
|
|
64,071
|
|
|||
|
Proceeds from repayment of employee note receivable
|
—
|
|
|
—
|
|
|
7,912
|
|
|||
|
Deferred offering costs paid
|
—
|
|
|
—
|
|
|
(7,821
|
)
|
|||
|
Dividend paid
|
—
|
|
|
—
|
|
|
(68,000
|
)
|
|||
|
Other, net
|
(490
|
)
|
|
(404
|
)
|
|
(657
|
)
|
|||
|
Net cash provided by (used in) financing activities
|
(5,564
|
)
|
|
(7,195
|
)
|
|
8,310
|
|
|||
|
|
|
|
|
|
|
||||||
|
Net increase (decrease) in cash and cash equivalents
|
41,146
|
|
|
(5,236
|
)
|
|
1,291
|
|
|||
|
Cash and cash equivalents - beginning of period
|
10,059
|
|
|
15,295
|
|
|
14,004
|
|
|||
|
Cash and cash equivalents - end of period
|
$
|
51,205
|
|
|
$
|
10,059
|
|
|
$
|
15,295
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
|
|
|
|||
|
Cash paid for interest
|
$
|
7,124
|
|
|
$
|
8,162
|
|
|
$
|
12,170
|
|
|
Cash paid for income taxes, net of refunds
|
4,085
|
|
|
5,673
|
|
|
8,466
|
|
|||
|
Supplemental disclosure of noncash investing and financing activities:
|
|
|
|
|
|
||||||
|
Accretion of preferred stock to maximum redemption value
|
—
|
|
|
—
|
|
|
436,317
|
|
|||
|
Deferred offering costs included in accounts payable and accrued expenses
|
—
|
|
|
—
|
|
|
193
|
|
|||
|
Property and equipment acquired under capital leases
|
2,098
|
|
|
10
|
|
|
3,000
|
|
|||
|
Property and equipment purchases included in accounts payable and
accrued expenses
|
1,838
|
|
|
1,143
|
|
|
491
|
|
|||
|
Vesting of shares related to early exercise of common stock options
|
—
|
|
|
4,074
|
|
|
7,859
|
|
|||
|
Note receivable issued to finance early exercise of common stock
|
—
|
|
|
—
|
|
|
(11,971
|
)
|
|||
|
Net repayment of note receivable with dividend proceeds
|
—
|
|
|
—
|
|
|
4,060
|
|
|||
|
|
Year ended December 31,
|
|||||||
|
|
2018
|
|
2017
|
|
2016
|
|||
|
Customer A
|
21
|
%
|
|
25
|
%
|
|
28
|
%
|
|
Customer B
|
30
|
%
|
|
29
|
%
|
|
30
|
%
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||
|
Customer A
|
27
|
%
|
|
29
|
%
|
|
Customer B
|
20
|
%
|
|
17
|
%
|
|
Customer C
|
*
|
|
|
17
|
%
|
|
|
|
Estimated
useful lives
|
|
Machinery, equipment and software
|
|
3-5 years
|
|
Leasehold improvements
|
|
5 years
|
|
Furniture and fixtures
|
|
2-5 years
|
|
Store fixtures
|
|
2-3 years
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
U.S.
|
$
|
240,612
|
|
|
$
|
243,299
|
|
|
$
|
210,236
|
|
|
International
|
26,823
|
|
|
26,589
|
|
|
19,331
|
|
|||
|
Total net sales
|
$
|
267,435
|
|
|
$
|
269,888
|
|
|
$
|
229,567
|
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||
|
U.S.
|
$
|
21,236
|
|
|
$
|
17,834
|
|
|
International
|
568
|
|
|
203
|
|
||
|
Total property and equipment, net
|
$
|
21,804
|
|
|
$
|
18,037
|
|
|
Balance as of December 31, 2015
|
$
|
3,866
|
|
|
Charges
|
24,427
|
|
|
|
Deductions
|
(16,366
|
)
|
|
|
Balance as of December 31, 2016
|
11,927
|
|
|
|
Charges
|
25,680
|
|
|
|
Deductions
|
(29,149
|
)
|
|
|
Balance as of December 31, 2017
|
8,458
|
|
|
|
Charges
|
26,971
|
|
|
|
Deductions
|
(27,655
|
)
|
|
|
Balance as of December 31, 2018
|
$
|
7,774
|
|
|
Recently adopted accounting standards
|
|||
|
Standard
|
Description
|
Date of expected adoption/adoption
|
Effect on the financial statements or other significant matters
|
|
ASU 2014-09,
Revenue from Contracts with Customers (Topic 606)
|
The new standard replaced all existing revenue recognition standards including industry-specific guidance and significantly expanded the disclosure requirements for revenue arrangements. It may be adopted either retrospectively or on a modified retrospective basis to new contracts and existing contracts with remaining performance obligations as of the effective date.
|
January 1, 2018
|
The Company adopted ASC 606 on a modified retrospective basis, and recognized a net reduction of $0.1 million to the opening balance of retained earnings, net of tax for the cumulative effect of applying the new standard. The results for periods beginning after January 1, 2018 are presented under ASC 606, while comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. The adoption of the new standard impacted net sales and accounts receivable. Net sales would have been $0.3 million higher under the previous standard in the year ended December 31, 2018. Accounts receivable would have been $0.4 million higher under the previous standard as of December 31, 2018.
|
|
ASU 2016-01,
Recognition and Measurement of Financial Assets and Financial Liabilities
|
The standard makes targeted improvements to US GAAP, including significant revisions to an entity’s accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value.
|
January 1, 2018
|
The Company adopted this standard in the first quarter of 2018. The standard impacted the methods used to assess and identify impairment of its investments. Additionally, the standard eliminates the requirement to disclose the methods and significant assumptions used to estimate the fair value of financial instruments that are measured at amortized cost on the balance sheet. The standard had no impact on the Company's consolidated financial statements.
|
|
Standards that are not yet adopted
|
|||
|
Standard
|
Description
|
Date of expected adoption/adoption
|
Effect on the financial statements or other significant matters
|
|
ASU 2016-02,
Leases (Topic 842)
|
The standard will require lessees to recognize a right-of-use asset and a lease liability for virtually all of their leases (other than leases that meet the definition of a short-term lease). The liability will be equal to the
present value of lease payments. The asset will be based on the liability, subject to adjustment, such as for initial direct costs. Lessor accounting is similar to the current model, but updated to align with certain changes to the lessee model (e.g., certain definitions, such as initial direct costs, have been updated) and the new revenue recognition standard. It requires a modified retrospective approach for all leases existing at, or entered into after, the date of initial application. |
January 1, 2019
|
The Company expects the standard to result in a material increase in long-term assets and long-term liabilities related to operating leases currently not recorded on the balance sheet. The Company is currently completing its implementation efforts and is continuing to evaluate other possible impacts of the adoption of this standard on its consolidated financial statements and related disclosures.
|
|
ASU 2018-15,
Intangibles-Goodwill and Other- Internal-Use Software (Subtopic 350-40)
|
The standard will require customers in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation costs to capitalize as assets or expense as incurred. Certain implementation costs incurred during the application development stage would be deferred and capitalized (e.g., costs of integration with on-premises software, coding, configuration, customization). Other costs incurred during the preliminary project and post-implementation stages would be expensed (e.g., planning the project, training, maintenance after implementation, data conversion). The amendments in the ASU can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption.
|
January 1, 2020
|
The Company is currently evaluating the effect of the standard on its consolidated financial statements and related disclosures.
|
|
|
Estimated useful life
|
|
Gross carrying amount
|
|
Accumulated amortization
|
|
Net carrying amount
|
||||||
|
Customer relationships – retailers
|
10 years
|
|
$
|
68,800
|
|
|
$
|
(33,827
|
)
|
|
$
|
34,973
|
|
|
Customer relationships – e-commerce
|
3 years
|
|
3,900
|
|
|
(3,900
|
)
|
|
—
|
|
|||
|
Total finite-lived intangibles
|
|
|
72,700
|
|
|
(37,727
|
)
|
|
34,973
|
|
|||
|
Trademarks
|
Indefinite
|
|
63,800
|
|
|
—
|
|
|
63,800
|
|
|||
|
Goodwill
|
|
|
157,264
|
|
|
—
|
|
|
157,264
|
|
|||
|
Total goodwill and other intangibles
|
|
|
$
|
293,764
|
|
|
$
|
(37,727
|
)
|
|
$
|
256,037
|
|
|
|
Estimated useful life
|
|
Gross carrying amount
|
|
Accumulated amortization
|
|
Net carrying amount
|
||||||
|
Customer relationships – retailers
|
10 years
|
|
$
|
68,800
|
|
|
$
|
(26,947
|
)
|
|
$
|
41,853
|
|
|
Customer relationships – e-commerce
|
3 years
|
|
3,900
|
|
|
(3,875
|
)
|
|
25
|
|
|||
|
Favorable leases, net
|
Varies
|
|
580
|
|
|
(376
|
)
|
|
204
|
|
|||
|
Total finite-lived intangibles
|
|
|
73,280
|
|
|
(31,198
|
)
|
|
42,082
|
|
|||
|
Trademarks
|
Indefinite
|
|
63,800
|
|
|
—
|
|
|
63,800
|
|
|||
|
Goodwill
|
|
|
157,264
|
|
|
—
|
|
|
157,264
|
|
|||
|
Total goodwill and other intangibles
|
|
|
$
|
294,344
|
|
|
$
|
(31,198
|
)
|
|
$
|
263,146
|
|
|
Year ending December 31,
|
|
||
|
2019
|
$
|
6,880
|
|
|
2020
|
6,880
|
|
|
|
2021
|
6,880
|
|
|
|
2022
|
6,880
|
|
|
|
2023
|
6,880
|
|
|
|
Thereafter
|
573
|
|
|
|
Total
|
$
|
34,973
|
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||
|
Machinery, equipment and software
|
$
|
13,007
|
|
|
$
|
6,733
|
|
|
Leasehold improvements
|
9,549
|
|
|
8,673
|
|
||
|
Furniture and fixtures
|
3,027
|
|
|
2,827
|
|
||
|
Store fixtures
|
13,481
|
|
|
10,896
|
|
||
|
Property and equipment, gross
|
39,064
|
|
|
29,129
|
|
||
|
Less: Accumulated depreciation and amortization
|
(17,260
|
)
|
|
(11,092
|
)
|
||
|
Property and equipment, net
|
$
|
21,804
|
|
|
$
|
18,037
|
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||
|
Accrued expenses
|
$
|
8,783
|
|
|
$
|
9,422
|
|
|
Other current liabilities
|
1,834
|
|
|
1,894
|
|
||
|
Accrued compensation
|
1,983
|
|
|
3,998
|
|
||
|
Income taxes payable
|
71
|
|
|
625
|
|
||
|
Accrued expenses and other current liabilities
|
$
|
12,671
|
|
|
$
|
15,939
|
|
|
|
|
|
Fair value measurements using
|
||||||||||||
|
|
Fair value
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
|
Financial liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Long-term debt, including current portion
(1)
|
$
|
150,719
|
|
|
$
|
—
|
|
|
$
|
150,719
|
|
|
$
|
—
|
|
|
Total financial liabilities
|
$
|
150,719
|
|
|
$
|
—
|
|
|
$
|
150,719
|
|
|
$
|
—
|
|
|
|
|
|
Fair value measurements using
|
||||||||||||
|
|
Fair value
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
|
Financial liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Long-term debt, including current portion
(1)
|
$
|
156,792
|
|
|
$
|
—
|
|
|
$
|
156,792
|
|
|
$
|
—
|
|
|
Total financial liabilities
|
$
|
156,792
|
|
|
$
|
—
|
|
|
$
|
156,792
|
|
|
$
|
—
|
|
|
•
|
On January 31, 2014, the Company entered into a senior secured credit facility (the “2014 Senior Secured Credit Facility”), which consisted of a
$20.0 million
revolving line of credit and a
$105.0 million
term loan. Also, on January 31, 2014, the Company entered into a
$40.0 million
second lien term loan (the “Second Lien Term Loan”).
|
|
•
|
On June 7, 2016, the Company incurred an incremental
$64.0 million
in term loan borrowings under the 2014 Senior Secured Credit Facility to fund, in part, a
$72.0 million
special dividend to stockholders, and increased the total availability under the revolving credit facility to
$25.0 million
.
|
|
•
|
On September 27, 2016, the Company used a portion of the proceeds from the initial public offering to repay the entire outstanding balance of
$40.0 million
from the Second Lien Term Loan.
|
|
•
|
On December 23, 2016, the Company refinanced its outstanding obligations under the 2014 Senior Secured Credit Facility, entering into a new
5
-year,
$200.0 million
senior secured credit agreement, as further described below.
|
|
•
|
On August 25, 2017, the Company amended its senior secured credit agreement to increase the total availability under the revolving line of credit to $
50.0 million
and to lower the interest rates and extend the maturity date to August 25, 2022.
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||
|
Debt:
|
|
|
|
||||
|
Term loan
|
$
|
146,737
|
|
|
$
|
154,418
|
|
|
Capital lease obligations
|
3,982
|
|
|
2,374
|
|
||
|
Total debt
|
150,719
|
|
|
156,792
|
|
||
|
Less: debt issuance costs
|
(335
|
)
|
|
(444
|
)
|
||
|
Total debt, net of issuance costs
|
150,384
|
|
|
156,348
|
|
||
|
Less: current portion
|
(9,861
|
)
|
|
(8,646
|
)
|
||
|
Long-term portion of debt
|
$
|
140,523
|
|
|
$
|
147,702
|
|
|
Year ending December 31,
|
Term Loan
|
|
Capital lease obligations
|
||||
|
2019
|
$
|
9,075
|
|
|
$
|
786
|
|
|
2020
|
11,138
|
|
|
801
|
|
||
|
2021
|
14,438
|
|
|
831
|
|
||
|
2022
|
113,849
|
|
|
846
|
|
||
|
2023
|
—
|
|
|
718
|
|
||
|
Thereafter
|
—
|
|
|
—
|
|
||
|
Total
|
$
|
148,500
|
|
|
$
|
3,982
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Interest on term loan debt
|
$
|
6,774
|
|
|
$
|
7,271
|
|
|
$
|
12,076
|
|
|
Amortization of debt issuance costs
|
792
|
|
|
810
|
|
|
1,281
|
|
|||
|
Loss on extinguishment of debt
|
—
|
|
|
—
|
|
|
2,736
|
|
|||
|
Interest on revolving line of credit
|
132
|
|
|
526
|
|
|
190
|
|
|||
|
Interest on capital leases
|
155
|
|
|
168
|
|
|
—
|
|
|||
|
Other
|
(37
|
)
|
|
—
|
|
|
—
|
|
|||
|
Interest expense, net
|
$
|
7,816
|
|
|
$
|
8,775
|
|
|
$
|
16,283
|
|
|
Year ending December 31,
|
|
|
|
|
2019
|
$
|
5,375
|
|
|
2020
|
5,210
|
|
|
|
2021
|
3,876
|
|
|
|
2022
|
2,832
|
|
|
|
2023
|
2,858
|
|
|
|
Thereafter
|
7,167
|
|
|
|
Total
|
$
|
27,318
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Domestic
|
$
|
17,405
|
|
|
$
|
22,409
|
|
|
$
|
9,677
|
|
|
Foreign
|
551
|
|
|
60
|
|
|
135
|
|
|||
|
Total
|
$
|
17,956
|
|
|
$
|
22,469
|
|
|
$
|
9,812
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Current:
|
|
|
|
|
|
|
|
||||
|
U.S. federal
|
$
|
(2,414
|
)
|
|
$
|
(2,058
|
)
|
|
$
|
(9,978
|
)
|
|
State
|
(948
|
)
|
|
(369
|
)
|
|
(2,096
|
)
|
|||
|
Foreign
|
(8
|
)
|
|
—
|
|
|
—
|
|
|||
|
Total current
|
(3,370
|
)
|
|
(2,427
|
)
|
|
(12,074
|
)
|
|||
|
Deferred:
|
|
|
|
|
|
|
|
||||
|
U.S. federal
|
1,005
|
|
|
13,246
|
|
|
8,384
|
|
|||
|
State
|
101
|
|
|
(21
|
)
|
|
(773
|
)
|
|||
|
Foreign
|
(167
|
)
|
|
208
|
|
|
(36
|
)
|
|||
|
Total deferred
|
939
|
|
|
13,433
|
|
|
7,575
|
|
|||
|
Total (provision) benefit for income taxes
|
$
|
(2,431
|
)
|
|
$
|
11,006
|
|
|
$
|
(4,499
|
)
|
|
|
Year ended December 31,
|
|||||||
|
|
2018
|
|
2017
|
|
2016
|
|||
|
Federal statutory rate
|
21.0
|
%
|
|
35.0
|
%
|
|
35.0
|
%
|
|
Federal tax deferred rate change
|
—
|
%
|
|
(53.8
|
)%
|
|
—
|
%
|
|
State tax, net of federal benefit
|
2.6
|
%
|
|
0.6
|
%
|
|
0.7
|
%
|
|
State tax deferred rate change, net of federal benefit
|
0.9
|
%
|
|
0.9
|
%
|
|
18.7
|
%
|
|
Nondeductible business expenses
|
1.4
|
%
|
|
—
|
%
|
|
2.0
|
%
|
|
Provision-to-return adjustment
|
(3.9
|
)%
|
|
—
|
%
|
|
—
|
%
|
|
Uncertain tax positions
|
(1.3
|
)%
|
|
(1.7
|
)%
|
|
2.0
|
%
|
|
Stock based compensation
|
(8.6
|
)%
|
|
(28.1
|
)%
|
|
(16.8
|
)%
|
|
Others
|
1.4
|
%
|
|
(1.9
|
)%
|
|
4.3
|
%
|
|
Effective tax rate
|
13.5
|
%
|
|
(49.0
|
)%
|
|
45.9
|
%
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||
|
Deferred tax assets:
|
|
|
|
||||
|
Compensation
|
$
|
928
|
|
|
$
|
1,056
|
|
|
Inventories and receivables
|
3,008
|
|
|
2,965
|
|
||
|
Accrued expenses
|
424
|
|
|
663
|
|
||
|
Stock compensation
|
5,175
|
|
|
3,497
|
|
||
|
Net operating losses
|
43
|
|
|
210
|
|
||
|
Other
|
898
|
|
|
925
|
|
||
|
Deferred tax assets
|
10,476
|
|
|
9,316
|
|
||
|
Deferred tax liabilities:
|
|
|
|
||||
|
Goodwill
|
2,618
|
|
|
2,214
|
|
||
|
Fixed assets
|
2,405
|
|
|
1,923
|
|
||
|
Intangible assets
|
24,591
|
|
|
25,962
|
|
||
|
Other
|
1,023
|
|
|
313
|
|
||
|
Deferred tax liabilities
|
30,637
|
|
|
30,412
|
|
||
|
Net deferred tax liabilities
|
$
|
20,161
|
|
|
$
|
21,096
|
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||
|
Deferred tax assets
|
$
|
56
|
|
|
$
|
245
|
|
|
Deferred tax liabilities
|
20,217
|
|
|
21,341
|
|
||
|
Net deferred tax liabilities
|
$
|
20,161
|
|
|
$
|
21,096
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Balance at beginning of year
|
$
|
764
|
|
|
$
|
1,208
|
|
|
$
|
1,256
|
|
|
Increases for prior year tax positions
|
—
|
|
|
63
|
|
|
438
|
|
|||
|
Increases for current year tax positions
|
173
|
|
|
68
|
|
|
103
|
|
|||
|
Decreases for prior year tax positions
|
(8
|
)
|
|
(1
|
)
|
|
(589
|
)
|
|||
|
Decreases due to settlements
|
—
|
|
|
(32
|
)
|
|
—
|
|
|||
|
Decreases due to statutes lapsing
|
(358
|
)
|
|
(542
|
)
|
|
—
|
|
|||
|
Balance at end of year
|
$
|
571
|
|
|
$
|
764
|
|
|
$
|
1,208
|
|
|
|
Options
outstanding
|
|
Weighted-average exercise price
|
|
Weighted-average remaining
contractual life
(in years)
|
|
Aggregate intrinsic
values
(in thousands)
(1)
|
|||||
|
Balance as of December 31, 2017
|
2,597,294
|
|
|
$
|
10.66
|
|
|
|
|
|
|
|
|
Granted
|
585,250
|
|
|
18.43
|
|
|
|
|
|
|
||
|
Exercised
|
(236,490
|
)
|
|
3.75
|
|
|
|
|
|
|
||
|
Canceled or forfeited
|
(199,384
|
)
|
|
10.56
|
|
|
|
|
|
|
||
|
Balance as of December 31, 2018
|
2,746,670
|
|
|
$
|
12.91
|
|
|
7.6
|
|
$
|
4,880
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Exercisable, December 31, 2018
|
1,399,451
|
|
|
$
|
9.14
|
|
|
6.9
|
|
$
|
4,200
|
|
|
(1)
|
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the Company's closing stock price of
$8.66
, as reported on the New York Stock Exchange on
December 31, 2018
.
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Stock-based compensation expense
|
$
|
3,219
|
|
|
$
|
2,435
|
|
|
$
|
4,286
|
|
|
Intrinsic value of options exercised
|
$
|
2,890
|
|
|
$
|
12,841
|
|
|
$
|
2,486
|
|
|
Weighted-average grant date fair value
of options granted (per share)
|
$
|
6.81
|
|
|
$
|
9.51
|
|
|
$
|
5.07
|
|
|
|
Year ended December 31,
|
|||||||
|
|
2018
|
|
2017
|
|
2016
|
|||
|
Expected term (in years)
|
6.3
|
|
|
6.2
|
|
|
5.9
|
|
|
Expected volatility
|
32.02
|
%
|
|
32.42
|
%
|
|
36.50
|
%
|
|
Risk-free interest rate
|
2.68
|
%
|
|
2.14
|
%
|
|
1.34
|
%
|
|
Expected dividend yield
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
|
Options
outstanding
|
|
Weighted-average exercise price
|
|
Weighted-average remaining
contractual life
(in years)
|
|
Aggregate intrinsic
values
(in thousands)
(1)
|
|||||
|
Balance as of December 31, 2017
|
2,406,537
|
|
|
$
|
6.58
|
|
|
|
|
|
||
|
Exercised
|
(901,505
|
)
|
|
2.54
|
|
|
|
|
|
|||
|
Canceled or forfeited
|
(22,250
|
)
|
|
12.95
|
|
|
|
|
|
|||
|
Balance as of December 31, 2018
|
1,482,782
|
|
|
$
|
8.94
|
|
|
6.3
|
|
$
|
7,120
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Exercisable, December 31, 2018
|
1,068,482
|
|
|
$
|
2.00
|
|
|
5.7
|
|
$
|
7,120
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Stock-based compensation expense
|
$
|
1,168
|
|
|
$
|
3,489
|
|
|
$
|
1,813
|
|
|
Intrinsic value of options exercised
|
$
|
8,669
|
|
|
$
|
42,874
|
|
|
$
|
—
|
|
|
Weighted-average grant date fair value
of options granted (per share)
|
$
|
—
|
|
|
$
|
10.65
|
|
|
$
|
1.52
|
|
|
|
Shares of restricted stock outstanding
|
|
Weighted-average grant date fair value
|
|||
|
Balance as of December 31, 2017
|
1,248,824
|
|
|
$
|
23.37
|
|
|
Granted
|
1,331,745
|
|
|
17.73
|
|
|
|
Vested
|
(376,130
|
)
|
|
22.96
|
|
|
|
Canceled or forfeited
|
(168,315
|
)
|
|
20.24
|
|
|
|
Balance as of December 31, 2018
|
2,036,124
|
|
|
$
|
20.01
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Stock-based compensation expense
|
$
|
12,434
|
|
|
$
|
7,550
|
|
|
$
|
700
|
|
|
Intrinsic value of RSUs released
|
$
|
6,280
|
|
|
$
|
3,398
|
|
|
$
|
—
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Numerator:
|
|
|
|
|
|
|
|
|
|||
|
Net income
|
$
|
15,525
|
|
|
$
|
33,475
|
|
|
$
|
5,313
|
|
|
Adjustments to numerator:
|
|
|
|
|
|
||||||
|
Dividend paid to preferred stockholders
|
—
|
|
|
—
|
|
|
(66,531
|
)
|
|||
|
Accretion of convertible preferred stock to maximum
redemption value
|
—
|
|
|
—
|
|
|
(436,317
|
)
|
|||
|
Net income (loss) attributable to common stockholders
|
$
|
15,525
|
|
|
$
|
33,475
|
|
|
$
|
(497,535
|
)
|
|
|
|
|
|
|
|
||||||
|
Denominator:
|
|
|
|
|
|
||||||
|
Weighted average common shares outstanding - basic
|
46,828,798
|
|
|
45,358,452
|
|
|
12,606,529
|
|
|||
|
Dilutive common equivalent shares from equity awards
|
2,439,818
|
|
|
4,016,306
|
|
|
—
|
|
|||
|
Weighted average common shares outstanding - diluted
|
49,268,616
|
|
|
49,374,758
|
|
|
12,606,529
|
|
|||
|
|
|
|
|
|
|
||||||
|
Net income (loss) per share:
|
|
|
|
|
|
||||||
|
Basic
|
$
|
0.33
|
|
|
$
|
0.74
|
|
|
$
|
(39.47
|
)
|
|
Diluted
|
$
|
0.32
|
|
|
$
|
0.68
|
|
|
$
|
(39.47
|
)
|
|
|
|
|
|
|
|
||||||
|
Weighted average anti-dilutive shares from outstanding equity awards excluded from diluted earnings per share
|
3,373,529
|
|
|
1,176,787
|
|
|
7,591,298
|
|
|||
|
|
Q1
|
|
Q2
|
|
Q3
|
|
Q4
(1)
|
||||||||
|
2018
|
|
|
|
|
|
|
|
||||||||
|
Net sales
|
$
|
65,920
|
|
|
$
|
59,055
|
|
|
$
|
63,889
|
|
|
$
|
78,571
|
|
|
Gross profit
|
$
|
40,208
|
|
|
$
|
36,645
|
|
|
$
|
38,969
|
|
|
$
|
46,919
|
|
|
Net income
|
$
|
690
|
|
|
$
|
1,248
|
|
|
$
|
3,915
|
|
|
$
|
9,672
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.01
|
|
|
$
|
0.03
|
|
|
$
|
0.08
|
|
|
$
|
0.20
|
|
|
Diluted
|
$
|
0.01
|
|
|
$
|
0.03
|
|
|
$
|
0.08
|
|
|
$
|
0.20
|
|
|
2017
|
|
|
|
|
|
|
|
||||||||
|
Net sales
|
$
|
60,574
|
|
|
$
|
55,856
|
|
|
$
|
71,865
|
|
|
$
|
81,593
|
|
|
Gross profit
|
$
|
38,228
|
|
|
$
|
35,890
|
|
|
$
|
42,913
|
|
|
$
|
47,694
|
|
|
Net income
|
$
|
2,160
|
|
|
$
|
3,970
|
|
|
$
|
5,865
|
|
|
$
|
21,480
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.05
|
|
|
$
|
0.09
|
|
|
$
|
0.13
|
|
|
$
|
0.47
|
|
|
Diluted
|
$
|
0.04
|
|
|
$
|
0.08
|
|
|
$
|
0.12
|
|
|
$
|
0.44
|
|
|
•
|
acceleration of rent expense related to e.l.f. retail store lease right-of-use assets of approximately
$16.0 million
;
|
|
•
|
write-offs of other assets, including property and equipment, of approximately
$5.0
to
$6.0 million
;
|
|
•
|
employee severance payments of approximately
$0.5 million
;
|
|
•
|
other costs of approximately
$1.5
to
$2.5 million
.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|